Neuralink, a company founded by billionaire Elon Musk, has received the green light to launch its first clinical trial in Canada. The step marks an important milestone in the development of its revolutionary device, designed to allow paralyzed people to interact with digital devices using only their thoughts. • A device that promises to revolutionize medicine The Canadian study will focus on evaluating the safety and functionality of the device, intended for patients with tetraplegia, who